Skip to main content
PMC home page
The BMJ logoLink to The BMJ
editorial
. 1993 Aug 28;307(6903):519–520. doi: 10.1136/bmj.307.6903.519

Steroid osteoporosis.

T D Spector, P N Sambrook
PMCID: PMC1678643  PMID: 8400970

Full text

PDF
519

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adami S., Fossaluzza V., Rossini M., Bertoldo F., Gatti D., Zamberlan N., Lo Cascio V. The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate. Bone Miner. 1991 Oct;15(1):73–81. doi: 10.1016/0169-6009(91)90111-c. [DOI] [PubMed] [Google Scholar]
  2. Adinoff A. D., Hollister J. R. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983 Aug 4;309(5):265–268. doi: 10.1056/NEJM198308043090502. [DOI] [PubMed] [Google Scholar]
  3. Butler R. C., Davie M. W., Worsfold M., Sharp C. A. Bone mineral content in patients with rheumatoid arthritis: relationship to low-dose steroid therapy. Br J Rheumatol. 1991 Apr;30(2):86–90. doi: 10.1093/rheumatology/30.2.86. [DOI] [PubMed] [Google Scholar]
  4. Compston J. E., Judd D., Crawley E. O., Evans W. D., Evans C., Church H. A., Reid E. M., Rhodes J. Osteoporosis in patients with inflammatory bowel disease. Gut. 1987 Apr;28(4):410–415. doi: 10.1136/gut.28.4.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Gennari C., Civitelli R. Glucocorticoid-induced osteoporosis. Clin Rheum Dis. 1986 Dec;12(3):637–654. [PubMed] [Google Scholar]
  6. Grecu E. O., Weinshelbaum A., Simmons R. Effective therapy of glucocorticoid-induced osteoporosis with medroxyprogesterone acetate. Calcif Tissue Int. 1990 May;46(5):294–299. doi: 10.1007/BF02563818. [DOI] [PubMed] [Google Scholar]
  7. Hooyman J. R., Melton L. J., 3rd, Nelson A. M., O'Fallon W. M., Riggs B. L. Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum. 1984 Dec;27(12):1353–1361. doi: 10.1002/art.1780271205. [DOI] [PubMed] [Google Scholar]
  8. Laan R. F., van Riel P. L., van Erning L. J., Lemmens J. A., Ruijs S. H., van de Putte L. B. Vertebral osteoporosis in rheumatoid arthritis patients: effect of low dose prednisone therapy. Br J Rheumatol. 1992 Feb;31(2):91–96. doi: 10.1093/rheumatology/31.2.91. [DOI] [PubMed] [Google Scholar]
  9. Leboff M. S., Wade J. P., Mackowiak S., el-Hajj Fuleihan G., Zangari M., Liang M. H. Low dose prednisone does not affect calcium homeostasis or bone density in postmenopausal women with rheumatoid arthritis. J Rheumatol. 1991 Mar;18(3):339–344. [PubMed] [Google Scholar]
  10. Luengo M., Picado C., Del Rio L., Guañabens N., Montserrat J. M., Setoain J. Vertebral fractures in steroid dependent asthma and involutional osteoporosis: a comparative study. Thorax. 1991 Nov;46(11):803–806. doi: 10.1136/thx.46.11.803. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lukert B. P., Johnson B. E., Robinson R. G. Estrogen and progesterone replacement therapy reduces glucocorticoid-induced bone loss. J Bone Miner Res. 1992 Sep;7(9):1063–1069. doi: 10.1002/jbmr.5650070909. [DOI] [PubMed] [Google Scholar]
  12. Messina O. D., Barreira J. C., Zanchetta J. R., Maldonado-Cocco J. A., Bogado C. E., Sebastián O. N., Flores D., Riopedre A. M., Redondo G., Lázaro A. Effect of low doses of deflazacort vs prednisone on bone mineral content in premenopausal rheumatoid arthritis. J Rheumatol. 1992 Oct;19(10):1520–1526. [PubMed] [Google Scholar]
  13. Peretz A., Praet J. P., Bosson D., Rozenberg S., Bourdoux P. Serum osteocalcin in the assessment of corticosteroid induced osteoporosis. Effect of long and short term corticosteroid treatment. J Rheumatol. 1989 Mar;16(3):363–367. [PubMed] [Google Scholar]
  14. Pocock N. A., Eisman J. A., Dunstan C. R., Evans R. A., Thomas D. H., Huq N. L. Recovery from steroid-induced osteoporosis. Ann Intern Med. 1987 Sep;107(3):319–323. doi: 10.7326/0003-4819-107-2-319. [DOI] [PubMed] [Google Scholar]
  15. Reid I. R., Heap S. W. Determinants of vertebral mineral density in patients receiving long-term glucocorticoid therapy. Arch Intern Med. 1990 Dec;150(12):2545–2548. [PubMed] [Google Scholar]
  16. Reid I. R., King A. R., Alexander C. J., Ibbertson H. K. Prevention of steroid-induced osteoporosis with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD). Lancet. 1988 Jan 23;1(8578):143–146. doi: 10.1016/s0140-6736(88)92721-3. [DOI] [PubMed] [Google Scholar]
  17. Sambrook P. N., Eisman J. A., Yeates M. G., Pocock N. A., Eberl S., Champion G. D. Osteoporosis in rheumatoid arthritis: safety of low dose corticosteroids. Ann Rheum Dis. 1986 Nov;45(11):950–953. doi: 10.1136/ard.45.11.950. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Sambrook P., Birmingham J., Kelly P., Kempler S., Nguyen T., Pocock N., Eisman J. Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin. N Engl J Med. 1993 Jun 17;328(24):1747–1752. doi: 10.1056/NEJM199306173282404. [DOI] [PubMed] [Google Scholar]
  19. Sambrook P., Birmingham J., Kempler S., Kelly P., Eberl S., Pocock N., Yeates M., Eisman J. Corticosteroid effects on proximal femur bone loss. J Bone Miner Res. 1990 Dec;5(12):1211–1216. doi: 10.1002/jbmr.5650051204. [DOI] [PubMed] [Google Scholar]
  20. Spector T. D., Hall G. M., McCloskey E. V., Kanis J. A. Risk of vertebral fracture in women with rheumatoid arthritis. BMJ. 1993 Feb 27;306(6877):558–558. doi: 10.1136/bmj.306.6877.558. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Verstraeten A., Dequeker J. Vertebral and peripheral bone mineral content and fracture incidence in postmenopausal patients with rheumatoid arthritis: effect of low dose corticosteroids. Ann Rheum Dis. 1986 Oct;45(10):852–857. doi: 10.1136/ard.45.10.852. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from BMJ : British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES